Forum's 'end of the pier show' as chairman departs

by DOUG COLLIE

The hundreds of shareholders in the Avocet and Gennfros 'disruptive technology' businesses have been told their company chairman and life president Martin Frost is now working for the mysterious Parachute Holdings (PCH) with other radical changes planned at the top of the group's structure, including Mr Frost's departure from directorships at Avocet.

Meanwhile a set of photographs has been posted on the Avocet Shareholders Independent Forum purporting to show a dilapidated pier and jetty on the shores of Loch Lomond which was purchased by the directors of an Avocet subsidiary for £200,000 in 2017 together with a narrow strip of land.

It is claimed on the Forum that the property in question changed hands for just £1,000 in 2012.

News of the managerial shake-up in the boardrooms of Avocet and Gennfros has been distributed in a document sent out by PCH's "Tim Carter" although so far frustrated investors appear to have been able to track down the multi-million pound global organisation or its senior staff members. Mr Carter has no designated job title, and there are no contact numbers for PCH.

In a long list of bullet points 'Mr Carter' tells readers: "Pleased to advise that Martin Frost is now working for PCH; Loch Lomond Heritage Limited and Martin Frost will cease to be directors of Avocet & Gennfros companies by June end; Due to ill health Mrs. Eirlys Lloyd’s company [sic] will shortly cease to be company secretary of any Avocet or Gennfros company.

"The registered office of any Avocet or Gennfros company shall soon be changed from Palace Street, Berwick-upon-Tweed; Dr. Bob Jennings (like Mr Frost a Gennfros life president) is being asked to lead Gennfros Limited’ R & D unit."

Carter then goes on to outline plans for the group's patent and intellectual property.

He says: "The old AFS patents along with pertinent trademarks shall be sold out of Avocet IP Limited.
The remaining intellectual property within Avocet IP Limited is to be independently valued with the probable assistance of the inventors Dr. Bob Jennings and Dr. Glyn Short – such valuation will then be used as the bottom purchase guideline for the sale of the Avocet IP Limited company to Gennfros Limited.

"The existing Gennfros intellectual property is to be valued as at June 2021. PCH is in discussions to commission further provisional Gennfros patents. In short there is good reason to believe that up to 50 more patents for Gennfros will be in commission by July."

According to Carter, PCH is seeking to call a Gennfros AGM for August 2021. Amongst other matters at this AGM PCH will be seeking to amend Gennfros Limited’s company articles so as to: Increase Gennfros’s issued share capital by a further 50 million ordinary shares; Grant PCH the right to convert Gennfros loan capital at the rate of £6 per one new ordinary share

"Additional non-legal matters to be considered at this AGM: Remuneration packages of senior staff; the appointment of independent company legal advisors; Confirmation of the appointment of auditors; NDAs [Non Disclosure Agreements] and company secrecy".

And finally it is announced that Mr Frost will lead company publicity including a new website which will go online on June 30th 2021. Each trusted Gennfros shareholder will receive a protected password for the private web section by June 28th 2021.

Commenting on the correspondence "From the desk of Tim Carter", a business expert and shareholder told us: "Tim Carter has impressive credentials – an MBA and a PhD. Individuals of this calibre can almost always be found by tracking their publication history. You do not obtain a PhD without publishing. Yet, despite extensive searching, I cannot find even one academic publication or journal where he is cited? Very strange".